世界の前立腺がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostate Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4769 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、前立腺がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん）、用途別市場規模（化学療法、ホルモン療法、標的療法、免疫療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・前立腺がんの市場動向 ・企業の競争状況、市場シェア ・前立腺がんの種類別市場規模と予測2016-2027（ホルモン感受性前立腺がん、ホルモン不応性前立腺がん） ・前立腺がんの用途別市場規模と予測2016-2027（化学療法、ホルモン療法、標的療法、免疫療法） ・前立腺がんの北米市場規模2016-2027（アメリカ、カナダ） ・前立腺がんの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astellas, Inc.、AstraZeneca plc、Johnson & Johnson、Sanofi S.A、Bristol Myers Squibb (BMS)、Bayer AG） ・結論

Prostate cancer is cancer that occurs in the prostate.

Market Analysis and Insights: Global Prostate Cancer Market
The global Prostate Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer market.

Global Prostate Cancer Scope and Market Size
Prostate Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormone sensitive prostate cancer
Hormone refractory prostate cancer

Segment by Application
Chemotherapy
Hormonal Therapy
Targeted Therapy
Immunotherapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas, Inc.
AstraZeneca plc
Johnson & Johnson
Sanofi S.A
Bristol Myers Squibb (BMS)
Bayer AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormone sensitive prostate cancer
1.2.3 Hormone refractory prostate cancer
1.3 Market by Application
1.3.1 Global Prostate Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chemotherapy
1.3.3 Hormonal Therapy
1.3.4 Targeted Therapy
1.3.5 Immunotherapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Market Perspective (2016-2027)
2.2 Prostate Cancer Growth Trends by Regions
2.2.1 Prostate Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Industry Dynamic
2.3.1 Prostate Cancer Market Trends
2.3.2 Prostate Cancer Market Drivers
2.3.3 Prostate Cancer Market Challenges
2.3.4 Prostate Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Players by Revenue
3.1.1 Global Top Prostate Cancer Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Revenue
3.4 Global Prostate Cancer Market Concentration Ratio
3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2020
3.5 Prostate Cancer Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Product Solution and Service
3.7 Date of Enter into Prostate Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Breakdown Data by Type
4.1 Global Prostate Cancer Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Breakdown Data by Application
5.1 Global Prostate Cancer Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Market Size (2016-2027)
6.2 North America Prostate Cancer Market Size by Type
6.2.1 North America Prostate Cancer Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Market Size by Application
6.3.1 North America Prostate Cancer Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Market Size by Country
6.4.1 North America Prostate Cancer Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Prostate Cancer Market Size (2016-2027)
7.2 Europe Prostate Cancer Market Size by Type
7.2.1 Europe Prostate Cancer Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Market Size by Application
7.3.1 Europe Prostate Cancer Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Market Size by Country
7.4.1 Europe Prostate Cancer Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Cancer Market Size (2016-2027)
9.2 Latin America Prostate Cancer Market Size by Type
9.2.1 Latin America Prostate Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Market Size by Application
9.3.1 Latin America Prostate Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Market Size by Country
9.4.1 Latin America Prostate Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas, Inc.
11.1.1 Astellas, Inc. Company Details
11.1.2 Astellas, Inc. Business Overview
11.1.3 Astellas, Inc. Prostate Cancer Introduction
11.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2016-2021)
11.1.5 Astellas, Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Prostate Cancer Introduction
11.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2016-2021)
11.2.5 AstraZeneca plc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Prostate Cancer Introduction
11.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Details
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Prostate Cancer Introduction
11.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2016-2021)
11.4.5 Sanofi S.A Recent Development
11.5 Bristol Myers Squibb (BMS)
11.5.1 Bristol Myers Squibb (BMS) Company Details
11.5.2 Bristol Myers Squibb (BMS) Business Overview
11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction
11.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2016-2021)
11.5.5 Bristol Myers Squibb (BMS) Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Prostate Cancer Introduction
11.6.4 Bayer AG Revenue in Prostate Cancer Business (2016-2021)
11.6.5 Bayer AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormone sensitive prostate cancer
Table 3. Key Players of Hormone refractory prostate cancer
Table 4. Global Prostate Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Prostate Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Prostate Cancer Market Share by Regions (2016-2021)
Table 8. Global Prostate Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Prostate Cancer Market Share by Regions (2022-2027)
Table 10. Prostate Cancer Market Trends
Table 11. Prostate Cancer Market Drivers
Table 12. Prostate Cancer Market Challenges
Table 13. Prostate Cancer Market Restraints
Table 14. Global Prostate Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Prostate Cancer Market Share by Players (2016-2021)
Table 16. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2020)
Table 17. Ranking of Global Top Prostate Cancer Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Cancer Product Solution and Service
Table 21. Date of Enter into Prostate Cancer Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Prostate Cancer Revenue Market Share by Type (2016-2021)
Table 25. Global Prostate Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Prostate Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Prostate Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Prostate Cancer Revenue Market Share by Application (2016-2021)
Table 29. Global Prostate Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Prostate Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Prostate Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Prostate Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Prostate Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Prostate Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Prostate Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Prostate Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Prostate Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Prostate Cancer Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Prostate Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 61. Astellas, Inc. Company Details
Table 62. Astellas, Inc. Business Overview
Table 63. Astellas, Inc. Prostate Cancer Product
Table 64. Astellas, Inc. Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 65. Astellas, Inc. Recent Development
Table 66. AstraZeneca plc Company Details
Table 67. AstraZeneca plc Business Overview
Table 68. AstraZeneca plc Prostate Cancer Product
Table 69. AstraZeneca plc Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca plc Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Prostate Cancer Product
Table 74. Johnson & Johnson Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Sanofi S.A Company Details
Table 77. Sanofi S.A Business Overview
Table 78. Sanofi S.A Prostate Cancer Product
Table 79. Sanofi S.A Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 80. Sanofi S.A Recent Development
Table 81. Bristol Myers Squibb (BMS) Company Details
Table 82. Bristol Myers Squibb (BMS) Business Overview
Table 83. Bristol Myers Squibb (BMS) Prostate Cancer Product
Table 84. Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 85. Bristol Myers Squibb (BMS) Recent Development
Table 86. Bayer AG Company Details
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Prostate Cancer Product
Table 89. Bayer AG Revenue in Prostate Cancer Business (2016-2021) & (US$ Million)
Table 90. Bayer AG Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Market Share by Type: 2020 VS 2027
Figure 2. Hormone sensitive prostate cancer Features
Figure 3. Hormone refractory prostate cancer Features
Figure 4. Global Prostate Cancer Market Share by Application: 2020 VS 2027
Figure 5. Chemotherapy Case Studies
Figure 6. Hormonal Therapy Case Studies
Figure 7. Targeted Therapy Case Studies
Figure 8. Immunotherapy Case Studies
Figure 9. Prostate Cancer Report Years Considered
Figure 10. Global Prostate Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Prostate Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Prostate Cancer Market Share by Regions: 2020 VS 2027
Figure 13. Global Prostate Cancer Market Share by Regions (2022-2027)
Figure 14. Global Prostate Cancer Market Share by Players in 2020
Figure 15. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2020
Figure 17. Global Prostate Cancer Revenue Market Share by Type (2016-2021)
Figure 18. Global Prostate Cancer Revenue Market Share by Type (2022-2027)
Figure 19. North America Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Prostate Cancer Market Share by Type (2016-2027)
Figure 21. North America Prostate Cancer Market Share by Application (2016-2027)
Figure 22. North America Prostate Cancer Market Share by Country (2016-2027)
Figure 23. United States Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Prostate Cancer Market Share by Type (2016-2027)
Figure 27. Europe Prostate Cancer Market Share by Application (2016-2027)
Figure 28. Europe Prostate Cancer Market Share by Country (2016-2027)
Figure 29. Germany Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Prostate Cancer Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Prostate Cancer Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Prostate Cancer Market Share by Region (2016-2027)
Figure 39. China Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Prostate Cancer Market Share by Type (2016-2027)
Figure 47. Latin America Prostate Cancer Market Share by Application (2016-2027)
Figure 48. Latin America Prostate Cancer Market Share by Country (2016-2027)
Figure 49. Mexico Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Prostate Cancer Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Prostate Cancer Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Prostate Cancer Market Share by Country (2016-2027)
Figure 55. Turkey Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Prostate Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Astellas, Inc. Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 59. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 61. Sanofi S.A Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 62. Bristol Myers Squibb (BMS) Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 63. Bayer AG Revenue Growth Rate in Prostate Cancer Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---